A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma. Huang G, Zhang J, Gong L, Huang Y, et al. BMC Cancer 2021;21:626.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang G, Zhang J, Gong L, Huang Y, et al. A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma. BMC Cancer 2021;21:626.
PMID: 34044809